Women who experienced severe maternal morbidity with their first birth were less likely to have more children, a retrospective Swedish population-based cohort study suggested. Among
Ready or not, the holidays are here. It’s a time when many Americans accustomed to preparing simple meals find themselves responsible for safely serving multi-dish
Worries that urate-lowering therapy (ULT) could speed renal failure in patients with gout and chronic kidney disease (CKD) are unfounded, data from Great Britain indicated.
Children who died soon after moderate or severe TBI had more bilateral brain swelling than adults. At autopsy, pediatric TBI patients had predominantly microvascular blood-brain
The investigational monoclonal antibody barzolvolimab significantly improved provocation test outcomes and reduced symptoms compared with placebo in patients with cold urticaria and symptomatic dermographism, according
Philadelphia’s beverage tax on sugary drinks was not associated with changes in pediatric weight outcomes 2 years after it took effect, researchers found. Among 2-
Acoramidis (Attruby) gained FDA approval for treating wild-type or variant transthyretin (TTR) amyloidosis cardiomyopathy (ATTR-CM), BridgeBio Pharma announced. Offering patients near-complete TTR stabilization in an
Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director
Findings from a post hoc analysis of the AREDS and AREDS2 studies were presented at the recent American Academy of Ophthalmology (AAO) meeting, showing that
HOUSTON — Two-thirds of patients with PI3K-mutant brain metastases responded to the maximum tolerated dose (MTD) of the small-molecule inhibitor paxalisib plus radiation therapy (RT),